āĻšā§āĻŽMRCK34 âĸ BVMF
add
āĻŽāĻžāϰā§āĻ āĻ
ā§āϝāĻžāύā§āĻĄ āĻā§
ā§Ģā§.ā§Ļā§¨Â R$
ā§§ā§ āĻ
āĻā§āĻā§, ā§Ģ:ā§Šā§:⧍ā§Ļ AM GMT -ā§Š · BRL · BVMF · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§Ģā§.ā§Šā§¨Â R$
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§Ģā§Ŧ.ā§Žā§ŠÂ R$ - ā§Ģā§.⧝ā§Ļ R$
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Ģā§Ļ.ā§¯ā§¨Â R$ - ā§ā§¯.ā§ā§ŠÂ R$
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
⧍ā§Ļ⧝.ā§Ŧā§§āĻā§ USD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§Š.ā§Ģā§Ļ āĻšāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻāĻŦāϰ⧠āϰā§ā§āĻā§
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(USD) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§§ā§Ģ.ā§Žā§§āĻļāĻ¤Â āĻā§ | -ā§§.⧝ā§Ļ% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Ŧā§Ē⧝.ā§§ā§Ļ āĻā§ | ā§.ā§Šā§§% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Ēā§Ē⧍.ā§ā§Ļ āĻā§ | -ā§§ā§Ž.ā§Žā§Ģ% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ā§¨ā§Ž.ā§Ļā§§ | -ā§§ā§.ā§¨ā§Ž% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ⧍.ā§§ā§Š | -ā§Ŧ.ā§Ģā§Ž% |
EBITDA | ā§Ŧā§¯ā§Ž.ā§ā§Ļ āĻā§ | -ā§Ŧ.⧍⧧% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§§ā§§.ā§Ē⧍% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(USD) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§Žā§Ŧ⧍.⧍ā§Ļ āĻā§ | -⧍ā§Ē.ā§Ļā§Ŧ% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§§ā§§ā§.ā§Ģ⧍āĻā§ | ā§Ē.ā§Šā§Ē% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Ŧā§Ž.ā§Ēā§ŦāĻļāĻ¤Â āĻā§ | -ā§Ļ.ā§ā§Ģ% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Ē⧝.ā§Ļā§ŦāĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ⧍ā§Ē⧝.ā§ā§ŽÂ āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ⧍.ā§¯ā§Š | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ⧧⧍.ā§ā§Š% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§§ā§.ā§Ŧā§Ŧ% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(USD) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Ēā§Ē⧍.ā§ā§Ļ āĻā§ | -ā§§ā§Ž.ā§Žā§Ģ% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ā§Šā§¨ā§¯.ā§Šā§Ļ āĻā§ | -ā§Ēā§§.ā§Ģā§Ž% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§ā§.ā§Ļā§Ļ āĻā§ | ⧍ā§.⧝ā§% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Šā§Ģā§Ģ.ā§Ŧā§Ļ āĻā§ | -ā§Šā§¯ā§¨.ā§Ēā§Š% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | -ā§Ŧā§Ģ.⧝ā§Ļ āĻā§ | -ā§§ā§§ā§§.ā§Ģā§Ŧ% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ⧍ā§Ēā§Š.ā§¨ā§¨Â āĻā§ | -ā§Šā§¯.ā§Šā§¯% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fourth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
ā§§ āĻāĻžāύā§, ā§§ā§Žā§¯ā§§
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§ā§Ē,ā§Ļā§Ļā§Ļ